The Cialis Dosing Appeal - Actavis Group PTC EHF and Others v ICOS Corporation and another
Jane Lambert Supreme Court (Lady Hale, Lords Kerr, Sumption, Hodge and Briggs) Actavis Group PTC EHF and others v ICOS Corporation and another [2019] UKSC 15 (27 March 2019) In The Cialis Litigation - Actavis Group PTC EHF and Others v Icos Corp and Another 4 Oct 2016, I discussed Mr Justice Birss's judgment in Actavis and others v Eli Lilly and Co [2016] EWHC 1955 (Pat) (10 Aug 2016) in which he dismissed a claim for the revocation of European patent (UK) No 1,173,181 "Compositions comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction" and held that the patent had been infringed, His judgment was reversed by the Court of Appeal (Lord Justices Lewison, Kitchin and Floyd) in Actavis Group PTC EHF and another v Teva UK Ltd and others [2017] EWCA Civ 1671, 159 BMLR 108, (2018) 159 BMLR 108, [2018] RPC 7 (1 Nov 2017) on the ground that the claims relied upon had been obvious. The patentee and its exclusive licensee in the UK